TABLE 3:

Demographic and treatment data in the 45 participants

DataLow RiskStandard or High Risk
No. of subjects
    After 1 course of IV MTX2123
    After 4 courses of IV MTX2021
    After 7 courses of IV MTX2121
    End of Therapy2017
Sex
    Male1011
    Female1212
Age at diagnosis (y)*5.0±2.79.2±4.8

  • * Data are the mean ± standard deviation.